ShanX MedTech awarded EUR 8.85M EU4Health contract for rapid AST

ShanX MedTech has been awarded an EU4Health contract worth EUR 8.85 million to lead a European joint tender developing a rapid point-of-care antimicrobial susceptibility test (AST). The contract was announced on December 18, 2025.

“ShanX MedTech has been awarded an EU4Health contract to lead a European joint tender developing a rapid point-of-care (POC) antimicrobial susceptibility test, a critical step in the fight against antimicrobial resistance (AMR).”shanxmedtech.com

• 1 source
• shanxmedtech.comEUR8,85 M Contract fuels ShanX MedTech–led advances in point-of-care AST - ShanX MedtechEriola-SophiaDec 18, 2025

Summarized from public sources; check the original articles before acting on it.